Cargando…

Trimetazidine Attenuates Heart Failure by Improving Myocardial Metabolism via AMPK

Energic deficiency of cardiomyocytes is a dominant cause of heart failure. An antianginal agent, trimetazidine improves the myocardial energetic supply. We presumed that trimetazidine protects the cardiomyocytes from the pressure overload-induced heart failure through improving the myocardial metabo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shu, Hongyang, Hang, Weijian, Peng, Yizhong, Nie, Jiali, Wu, Lujin, Zhang, Wenjun, Wang, Dao Wen, Zhou, Ning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479198/ https://www.ncbi.nlm.nih.gov/pubmed/34603021 http://dx.doi.org/10.3389/fphar.2021.707399

Ejemplares similares

Trimetazidine in Heart Failure
por: Shu, Hongyang, et al.
Publicado: (2021)

Trimetazidine Ameliorates Myocardial Metabolic Remodeling in Isoproterenol-Induced Rats Through Regulating Ketone Body Metabolism via Activating AMPK and PPAR α
por: Li, Huihui, et al.
Publicado: (2020)

The role of CD36 in cardiovascular disease
por: Shu, Hongyang, et al.
Publicado: (2020)

Trimetazidine Attenuates Exhaustive Exercise-Induced Myocardial Injury in Rats via Regulation of the Nrf2/NF-κB Signaling Pathway
por: Zhang, Hongming, et al.
Publicado: (2019)

Effects of ivabradine hydrochloride combined with trimetazidine on myocardial fibrosis in rats with chronic heart failure
por: Ma, Dongwen, et al.
Publicado: (2019)

Protective Effect of Trimetazidine on Potassium Ion Homeostasis in Myocardial Tissue in Mice with Heart Failure
por: Yang, Kaijing, et al.
Publicado: (2022)

Emerging role of VCP/p97 in cardiovascular diseases: novel insights and therapeutic opportunities
por: Shu, Hongyang, et al.
Publicado: (2021)

Function and Mechanism of Trimetazidine in Myocardial Infarction-Induced Myocardial Energy Metabolism Disorder Through the SIRT1–AMPK Pathway
por: Luo, Xiu-ying, et al.
Publicado: (2021)

Is Treatment with Trimetazidine Beneficial in Patients with Chronic Heart Failure?
por: Zhou, Xiang, et al.
Publicado: (2014)

Trimetazidine Inhibits Renal Tubular Epithelial Cells to Mesenchymal Transition in Diabetic Rats via Upregulation of Sirt1
por: Yang, Yong, et al.
Publicado: (2020)

Emerging Roles of Ceramide in Cardiovascular Diseases
por: Shu, Hongyang, et al.
Publicado: (2022)

N-Acetyl Cysteine Ameliorates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease and Intracellular Triglyceride Accumulation by Preserving Mitochondrial Function
por: Hang, Weijian, et al.
Publicado: (2021)

Trimetazidine Attenuates Cardiac Dysfunction in Endotoxemia and Sepsis by Promoting Neutrophil Migration
por: Chen, Jing, et al.
Publicado: (2018)

Linggui Zhugan Decoction activates the SIRT1-AMPK-PGC1α signaling pathway to improve mitochondrial and oxidative damage in rats with chronic heart failure caused by myocardial infarction
por: Yu, Siyi, et al.
Publicado: (2023)

Irisin Attenuates Myocardial Ischemia/Reperfusion Injury and Improves Mitochondrial Function Through AMPK Pathway in Diabetic Mice
por: Xin, Chao, et al.
Publicado: (2020)

Trimetazidine Modulates Mitochondrial Redox Status and Disrupted Glutamate Homeostasis in a Rat Model of Epilepsy
por: Al-Shorbagy, Muhammad Y., et al.
Publicado: (2021)

Trimetazidine therapy for diabetic mouse hearts subjected to ex vivo acute heart failure
por: Breedt, Emilene, et al.
Publicado: (2017)

The Role of Myocardial Mitochondrial Quality Control in Heart Failure
por: Qiu, Zhiling, et al.
Publicado: (2019)

Exogenous Hydrogen Sulfide Ameliorates Diabetic Myocardial Fibrosis by Inhibiting Cell Aging Through SIRT6/AMPK Autophagy
por: Li, Yaling, et al.
Publicado: (2020)

Naringenin Attenuates Non-Alcoholic Fatty Liver Disease by Enhancing Energy Expenditure and Regulating Autophagy via AMPK
por: Yang, Ying, et al.
Publicado: (2021)

Evaluation of the Efficacy and Safety of Chinese Herbal Injection Combined With Trimetazidine for Viral Myocarditis: A Network Meta-Analysis
por: Wu, Kerui, et al.
Publicado: (2021)

Trimetazidine enhances myocardial angiogenesis in pressure overload-induced cardiac hypertrophy mice through directly activating Akt and promoting the binding of HSF1 to VEGF-A promoter
por: Shu, Hong-yang, et al.
Publicado: (2022)

Dapagliflozin Attenuates Myocardial Fibrosis by Inhibiting the TGF-β1/Smad Signaling Pathway in a Normoglycemic Rabbit Model of Chronic Heart Failure
por: Chen, Xuefeng, et al.
Publicado: (2022)

RBM20, a Therapeutic Target to Alleviate Myocardial Stiffness via Titin Isoforms Switching in HFpEF
por: Li, Na, et al.
Publicado: (2022)

Value of PTEN and Echocardiography in Predicting the Efficacy of Trimetazidine Combined with Metoprolol in the Treatment of Heart Failure
por: Feng, Xue-Hong, et al.
Publicado: (2021)

Metformin Attenuates Silica-Induced Pulmonary Fibrosis by Activating Autophagy via the AMPK-mTOR Signaling Pathway
por: Li, Shu-xian, et al.
Publicado: (2021)

Trimetazidine ameliorates sunitinib-induced cardiotoxicity in mice via the AMPK/mTOR/autophagy pathway
por: Yang, Yi, et al.
Publicado: (2019)

Liquiritin Attenuates Pathological Cardiac Hypertrophy by Activating the PKA/LKB1/AMPK Pathway
por: Aiyasiding, Xiahenazi, et al.
Publicado: (2022)

Berberine Ameliorates High Glucose-Induced Cardiomyocyte Injury via AMPK Signaling Activation to Stimulate Mitochondrial Biogenesis and Restore Autophagic Flux
por: Hang, Weijian, et al.
Publicado: (2018)

Effects of bisoprolol in combination with trimetazidine on the treatment of heart failure and concomitant chronic obstructive pulmonary disease
por: Ke, Yuanyuan, et al.
Publicado: (2016)

Trimetazidine in heart failure with preserved ejection fraction: a randomized controlled cross‐over trial
por: van de Bovenkamp, Arno A., et al.
Publicado: (2023)

CTRP5-Overexpression Attenuated Ischemia-Reperfusion Associated Heart Injuries and Improved Infarction Induced Heart Failure
por: Peng, Meng, et al.
Publicado: (2020)

Follistatin Attenuates Myocardial Fibrosis in Diabetic Cardiomyopathy via the TGF-β–Smad3 Pathway
por: Wang, Yinhui, et al.
Publicado: (2021)

Obesity and atrial fibrillation: a narrative review from arrhythmogenic mechanisms to clinical significance
por: Shu, Hongyang, et al.
Publicado: (2023)

Activating AMPK to Restore Tight Junction Assembly in Intestinal Epithelium and to Attenuate Experimental Colitis by Metformin
por: Chen, Lu, et al.
Publicado: (2018)

Role of metabolic manipulator trimetazidine in limiting percutaneous coronary intervention–induced myocardial injury
por: Kazmi, Danish H., et al.
Publicado: (2018)

Proteomic Analysis Reveals the Protective Effects of Yiqi Fumai Lyophilized Injection on Chronic Heart Failure by Improving Myocardial Energy Metabolism
por: Han, Xiaoying, et al.
Publicado: (2021)

Effects of sacubitril-valsartan on heart failure patients with mid-range ejection fractions: A systematic review and meta-analysis
por: Qin, Jianbin, et al.
Publicado: (2022)

Wedelolactone Attenuates Pulmonary Fibrosis Partly Through Activating AMPK and Regulating Raf-MAPKs Signaling Pathway
por: Yang, Jin-yu, et al.
Publicado: (2019)

LncRNA Chaer Prevents Cardiomyocyte Apoptosis From Acute Myocardial Infarction Through AMPK Activation
por: He, Zhiyu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_igc2v1spi8ikvqj9v4adlvrgeu